International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2024
Indexing Partners
Coronary Stenosis in a Patient Under Pazopanib Therapy: A Case Study
Author(s) | Nadir Wydad, Lkhoyaali Siham, Hachlaf Mariem, Abdi Chaimae, Lemsyeh Hajar, Boutayeb Saber, El ghissassi Ibrahim, M’rabti Hind, Errihani Hassan |
---|---|
Country | Maroc |
Abstract | Tyrosine kinase inhibitors have transformed therapeutic approaches to cancer, marking a major advance in oncology. This article presents the clinical case of a 59-year-old moroccan patient with metastatic clear cell kidney cancer treated with pazopanib, who developed a cardiac vascular accident through coronary stenosis after 24 months of treatment with pazopanib. The main objective of this article is to illustrate the side effects of anti-angiogenic drugs and the crucial importance of monitoring these toxicities, particularly those of vascular origin, in order to prevent serious complications that could compromise the prognosis of a patient, regardless of the cancer disease itself. This case highlights the need for regular assessment of cardiovascular risk factors in patients receiving treatment with pazopanib, as well as increased vigilance for the appearance of signs or symptoms suggesting hematological or hepatic toxicities. Early and appropriate management of toxicities is essential to optimize the safety and effectiveness of renal cancer treatment with pazopanib, while preserving the patient's cardiovascular health. |
Keywords | Tyrosine kinase, Pazopanib, oncocardiology, kidney cancer |
Field | Médical / Pharmacie |
Published In | Volume 6, Issue 3, May-June 2024 |
Published On | 2024-06-23 |
Cite This | Coronary Stenosis in a Patient Under Pazopanib Therapy: A Case Study - Nadir Wydad, Lkhoyaali Siham, Hachlaf Mariem, Abdi Chaimae, Lemsyeh Hajar, Boutayeb Saber, El ghissassi Ibrahim, M’rabti Hind, Errihani Hassan - IJFMR Volume 6, Issue 3, May-June 2024. DOI 10.36948/ijfmr.2024.v06i03.22922 |
DOI | https://doi.org/10.36948/ijfmr.2024.v06i03.22922 |
Short DOI | https://doi.org/gt2447 |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.